Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Doreen Goerss"'
Autor:
Nils Heinzinger, Anne Maass, David Berron, Renat Yakupov, Oliver Peters, Jochen Fiebach, Kersten Villringer, Lukas Preis, Josef Priller, Eike Jacob Spruth, Slawek Altenstein, Anja Schneider, Klaus Fliessbach, Jens Wiltfang, Claudia Bartels, Frank Jessen, Franziska Maier, Wenzel Glanz, Katharina Buerger, Daniel Janowitz, Robert Perneczky, Boris-Stephan Rauchmann, Stefan Teipel, Ingo Killimann, Doreen Göerß, Christoph Laske, Matthias H. Munk, Annika Spottke, Nina Roy, Michael T. Heneka, Frederic Brosseron, Laura Dobisch, Michael Ewers, Peter Dechent, John Dylan Haynes, Klaus Scheffler, Steffen Wolfsgruber, Luca Kleineidam, Matthias Schmid, Moritz Berger, Emrah Düzel, Gabriel Ziegler, for the Alzheimer’s Disease Neuroimaging Initiative
Publikováno v:
Alzheimer’s Research & Therapy, Vol 15, Iss 1, Pp 1-18 (2023)
Abstract Background The NIA-AA proposed amyloid-tau-neurodegeneration (ATN) as a classification system for AD biomarkers. The amyloid cascade hypothesis (ACH) implies a sequence across ATN groups that patients might undergo during transition from hea
Externí odkaz:
https://doaj.org/article/3e1d5f4982d94dcfb401907b7983080b
Autor:
Niklas Vockert, Judith Machts, Luca Kleineidam, Aditya Nemali, Enise I. Incesoy, Jose Bernal, Hartmut Schütze, Renat Yakupov, Oliver Peters, Daria Gref, Luisa Sophie Schneider, Lukas Preis, Josef Priller, Eike Jakob Spruth, Slawek Altenstein, Anja Schneider, Klaus Fliessbach, Jens Wiltfang, Ayda Rostamzadeh, Wenzel Glanz, Stefan Teipel, Ingo Kilimann, Doreen Goerss, Christoph Laske, Matthias H. Munk, Annika Spottke, Nina Roy, Michael T. Heneka, Frederic Brosseron, Michael Wagner, Steffen Wolfsgruber, Laura Dobisch, Peter Dechent, Stefan Hetzer, Klaus Scheffler, Peter Zeidman, Yaakov Stern, Björn H. Schott, Frank Jessen, Emrah Düzel, Anne Maass, Gabriel Ziegler, the DELCODE study group
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract The cognitive reserve (CR) hypothesis posits that individuals can differ in how their brain function is disrupted by pathology associated with aging and neurodegeneration. Here, we test this hypothesis in the continuum from cognitively norma
Externí odkaz:
https://doaj.org/article/d47f0410fc5e498aa3d4d536cb833fd9
Autor:
Inga Menze, Jose Bernal, Pinar Kaya, Çağla Aki, Malte Pfister, Jonas Geisendörfer, Renat Yakupov, Roberto Duarte Coello, Maria d. C. Valdés-Hernández, Michael T. Heneka, Frederic Brosseron, Matthias C. Schmid, Wenzel Glanz, Enise I. Incesoy, Michaela Butryn, Ayda Rostamzadeh, Dix Meiberth, Oliver Peters, Lukas Preis, Dominik Lammerding, Daria Gref, Josef Priller, Eike J. Spruth, Slawek Altenstein, Andrea Lohse, Stefan Hetzer, Anja Schneider, Klaus Fliessbach, Okka Kimmich, Ina R. Vogt, Jens Wiltfang, Claudia Bartels, Björn H. Schott, Niels Hansen, Peter Dechent, Katharina Buerger, Daniel Janowitz, Robert Perneczky, Boris-Stephan Rauchmann, Stefan Teipel, Ingo Kilimann, Doreen Goerss, Christoph Laske, Matthias H. Munk, Carolin Sanzenbacher, Petra Hinderer, Klaus Scheffler, Annika Spottke, Nina Roy-Kluth, Falk Lüsebrink, Katja Neumann, Joanna Wardlaw, Frank Jessen, Stefanie Schreiber, Emrah Düzel, Gabriel Ziegler
Publikováno v:
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-16 (2024)
Abstract Background Perivascular space (PVS) enlargement in ageing and Alzheimer’s disease (AD) and the drivers of such a structural change in humans require longitudinal investigation. Elucidating the effects of demographic factors, hypertension,
Externí odkaz:
https://doaj.org/article/63eb7743209c40979f7c3e0fd2e5303c
Autor:
Doreen Goerss, Stefanie Köhler, Eleonora Rong, Anna Gesine Temp, Ingo Kilimann, Gerald Bieber, Stefan Teipel
Publikováno v:
JMIR Aging, Vol 7, p e50107 (2024)
BackgroundAssistive technologies can help people living with dementia maintain their everyday activities. Nevertheless, there is a gap between the potential and use of these materials. Involving future users may help close this gap, but the impact on
Externí odkaz:
https://doaj.org/article/cdee35f1d0854a72a231bd6113fa177a
Autor:
Lara Blömeke, Fabian Rehn, Victoria Kraemer‐Schulien, Janine Kutzsche, Marlene Pils, Tuyen Bujnicki, Piotr Lewczuk, Johannes Kornhuber, Silka D. Freiesleben, Luisa‐Sophie Schneider, Lukas Preis, Josef Priller, Eike J. Spruth, Slawek Altenstein, Andrea Lohse, Anja Schneider, Klaus Fliessbach, Jens Wiltfang, Niels Hansen, Ayda Rostamzadeh, Emrah Düzel, Wenzel Glanz, Enise I. Incesoy, Michaela Butryn, Katharina Buerger, Daniel Janowitz, Michael Ewers, Robert Perneczky, Boris‐Stephan Rauchmann, Stefan Teipel, Ingo Kilimann, Doreen Goerss, Christoph Laske, Matthias H. Munk, Carolin Sanzenbacher, Annika Spottke, Nina Roy‐Kluth, Michael T. Heneka, Frederic Brosseron, Michael Wagner, Steffen Wolfsgruber, Luca Kleineidam, Melina Stark, Matthias Schmid, Frank Jessen, Oliver Bannach, Dieter Willbold, Oliver Peters
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 16, Iss 2, Pp n/a-n/a (2024)
Abstract INTRODUCTION Soluble amyloid beta (Aβ) oligomers have been suggested as initiating Aβ related neuropathologic change in Alzheimer's disease (AD) but their quantitative distribution and chronological sequence within the AD continuum remain
Externí odkaz:
https://doaj.org/article/4bb37b34bcf7452db948167c1f2af3cc
Autor:
Felix Schulze, Steffen Müller, Xiati Guli, Lukas Schumann, Hannes Brehme, Till Riffert, Marco Rohde, Doreen Goerss, Simone Rackow, Anne Einsle, Timo Kirschstein, Rüdiger Köhling
Publikováno v:
Frontiers in Cellular Neuroscience, Vol 14 (2020)
PurposeEpilepsy therapy is currently based on anti-seizure drugs that do not modify the course of the disease, i.e., they are not anti-epileptogenic in nature. Previously, we observed that in vivo casein kinase 2 (CK2) inhibition with 4,5,6,7-tetrabr
Externí odkaz:
https://doaj.org/article/a549a4bd1146428f822827468387da25
Autor:
Milan Nemy, Martin Dyrba, Frederic Brosseron, Katharina Buerger, Peter Dechent, Laura Dobisch, Michael Ewers, Klaus Fliessbach, Wenzel Glanz, Doreen Goerss, Michael T Heneka, Stefan Hetzer, Enise I Incesoy, Daniel Janowitz, Ingo Kilimann, Christoph Laske, Franziska Maier, Matthias H Munk, Robert Perneczky, Oliver Peters, Lukas Preis, Josef Priller, Boris-Stephan Rauchmann, Sandra Röske, Nina Roy, Klaus Scheffler, Anja Schneider, Björn H Schott, Annika Spottke, Eike J Spruth, Michael Wagner, Jens Wiltfang, Renat Yakupov, Maria Eriksdotter, Eric Westman, Olga Stepankova, Lenka Vyslouzilova, Emrah Düzel, Frank Jessen, Stefan J Teipel, Daniel Ferreira
Publikováno v:
Nemy, M, Dyrba, M, Brosseron, F, Buerger, K, Dechent, P, Dobisch, L, Ewers, M, Fliessbach, K, Glanz, W, Goerss, D, Heneka, M T, Hetzer, S, Incesoy, E I, Janowitz, D, Kilimann, I, Laske, C, Maier, F, Munk, M H, Perneczky, R, Peters, O, Preis, L, Priller, J, Rauchmann, B-S, Röske, S, Roy, N, Scheffler, K, Schneider, A, Schott, B H, Spottke, A, Spruth, E J, Wagner, M, Wiltfang, J, Yakupov, R, Eriksdotter, M, Westman, E, Stepankova, O, Vyslouzilova, L, Düzel, E, Jessen, F, Teipel, S J & Ferreira, D 2022, ' Cholinergic white matter pathways along the Alzheimer's disease continuum ', Brain . https://doi.org/10.1093/brain/awac385
Brain 146(5), 2075-2088 (2023). doi:10.1093/brain/awac385
Brain 146(5), 2075-2088 (2023). doi:10.1093/brain/awac385
Previous studies have shown that the cholinergic nucleus basalis of Meynert and its white matter projections are affected in Alzheimer’s disease dementia and mild cognitive impairment. However, it is still unknown whether these alterations can be f
Publikováno v:
Alzheimer's and dementia 18(S2), (2022). doi:10.1002/alz.062249
Alzheimer's Association International Conference 2022
Alzheimer's Association International Conference 2022
Assistive technologies show promising features to support people with cognitive impairment in daily life, e.g. mobile sensors for falls detection or getting lost. On the other hand, smartwatches bear potential to not only monitor but also interact wi
Autor:
Niklas Vockert, Hartmut Schütze, Anni Richter, Slawek Altenstein, Claudia Bartels, Frederic Brosseron, Arturo Cardenas‐Blanco, Philip Dahmen, Peter Dechent, Laura Dobisch, Klaus Fließbach, Silka Dawn Freiesleben, Wenzel Glanz, Doreen Goerss, John‐Dylan Haynes, Michael T. Heneka, Ingo Kilimann, Okka Kimmich, Luca Kleineidam, Christoph Laske, Andrea Lohse, Coraline D. Metzger, Matthias H. J. Munk, Oliver Peters, Lukas Preis, Josef Priller, Alfredo Ramirez, Sandra Roeske, Ayda Rostamzadeh, Nina Roy, Klaus Scheffler, Anja Schneider, Annika Spottke, Eike Jakob Spruth, Stefan Teipel, Michael Wagner, Jens Wiltfang, Steffen Wolfsgruber, Renat Yakupov, Peter Zeidman, Frank Jessen, Björn H Schott, Emrah Duzel, Anne Maass, Gabriel Ziegler
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Konrad F. Waschkies, Joram Soch, Margarita Darna, Anni Richter, Slawek Altenstein, Aline Beyle, Frederic Brosseron, Friederike Buchholz, Michaela Butryn, Laura Dobisch, Michael Ewers, Klaus Fliessbach, Tatjana Gabelin, Wenzel Glanz, Doreen Goerss, Daria Gref, Daniel Janowitz, Ingo Kilimann, Andrea Lohse, Matthias H. Munk, Boris-Stephan Rauchmann, Ayda Rostamzadeh, Nina Roy, Eike Jakob Spruth, Peter Dechent, Michael T. Heneka, Stefan Hetzer, Alfredo Ramirez, Klaus Scheffler, Katharina Buerger, Christoph Laske, Robert Perneczky, Oliver Peters, Josef Priller, Anja Schneider, Annika Spottke, Stefan Teipel, Emrah Düzel, Frank Jessen, Jens Wiltfang, Björn H. Schott, Jasmin M. Kizilirmak
ObjectivesThe main goal of machine learning approaches to classify people into healthy, increased Alzheimer’s disease (AD) risk, and AD is the identification of valuable predictors for valid classification, prediction of conversion, and automatizat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01195020b5db4748e71c50f36351cefe
https://doi.org/10.1101/2022.11.30.22282930
https://doi.org/10.1101/2022.11.30.22282930